Yichen Dong
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Tumor Mass Is a Better Prognostic Factor Than Consolidation-to-Tumor Ratio in Invasive Lung Adenocarcinoma Manifest Difficult-to-Measure Solid Portion.
Journal: JTO clinical and research reports
Published: September 02, 2025
Bronchial sleeve lobectomy with pulmonary artery reconstruction following neoadjuvant chemoimmunotherapy: A propensity score-weighted comparison.
Journal: JTCVS open
Published: June 20, 2025
Survival benefits in non-small cell lung cancer during the immune checkpoint inhibitor era: integrating lymph node burden for prognostic precision.
Journal: Translational lung cancer research
Published: April 16, 2025
Validation and refinement of the ninth edition ypN descriptor in patients with non-small cell lung cancer receiving neoadjuvant therapy.
Journal: The Journal of thoracic and cardiovascular surgery
Published: April 15, 2025
Prognostic Impact and Recurrence Pattern of KRAS G12C Mutation in Surgically Resected Non-Small Cell Lung Cancer.
Journal: The Annals of thoracic surgery
Published: October 12, 2024
Comparison of Short- and Long-term Outcomes in Patients Undergoing Sleeve Lobectomy With or Without Buttressing the Bronchial Anastomosis.
Journal: The Annals of thoracic surgery
Published: September 15, 2024
Prognostic Impact of Adjuvant Immunotherapy in Patients With Resectable NSCLC After Neoadjuvant Chemoimmunotherapy: A Brief Report.
Journal: JTO clinical and research reports
Published: July 25, 2024
Predicting therapeutic response to neoadjuvant immunotherapy based on an integration model in resectable stage IIIA (N2) non-small cell lung cancer.
Journal: The Journal of thoracic and cardiovascular surgery
Published: January 23, 2024
Showing 1-9 of 9
Last Updated: 09/26/2026